AR030554A1 - Moleculas similares a receptores il-17 y usos de las mismas - Google Patents
Moleculas similares a receptores il-17 y usos de las mismasInfo
- Publication number
- AR030554A1 AR030554A1 ARP010101203A ARP010101203A AR030554A1 AR 030554 A1 AR030554 A1 AR 030554A1 AR P010101203 A ARP010101203 A AR P010101203A AR P010101203 A ARP010101203 A AR P010101203A AR 030554 A1 AR030554 A1 AR 030554A1
- Authority
- AR
- Argentina
- Prior art keywords
- receptors
- same
- similar molecules
- polypeptides
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Nuevos polipéptidos similares a receptores IL-17 y moléculas de ácido nucleico que los codifican. El invento también se refiere a vectores, células huésped, agonistas y antagonistas (incluyendo agentes enlazantes selectivos) y métodos para producir polipéptidos semejantes a receptores IL-17. También se proveen métodos para el tratamiento, diagnostico, mejora o prevencion de enfermedades con polipéptidos similares a receptores IL-17.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18992300P | 2000-03-16 | 2000-03-16 | |
US20420800P | 2000-05-12 | 2000-05-12 | |
US72323200A | 2000-11-27 | 2000-11-27 | |
US26615901P | 2001-02-02 | 2001-02-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030554A1 true AR030554A1 (es) | 2003-08-27 |
Family
ID=27497823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010101203A AR030554A1 (es) | 2000-03-16 | 2001-03-15 | Moleculas similares a receptores il-17 y usos de las mismas |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1265924A2 (es) |
JP (1) | JP2003527117A (es) |
AR (1) | AR030554A1 (es) |
AU (2) | AU5902901A (es) |
CA (1) | CA2401273A1 (es) |
MX (1) | MXPA02009024A (es) |
TW (1) | TWI322154B (es) |
WO (1) | WO2001068705A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7771719B1 (en) * | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
EP2333069A3 (en) | 1998-05-15 | 2011-09-14 | Genentech, Inc. | Therapeutic uses of IL-17 homologous polypeptides |
EP1897943B1 (en) * | 1999-12-23 | 2011-12-14 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU2007202616B2 (en) * | 2000-06-22 | 2011-08-18 | Amgen Inc. | IL-17 Like Molecules and Uses Thereof |
CA2425506A1 (en) * | 2000-10-18 | 2002-08-01 | Immunex Corporation | Methods for treating rheumatoid arthritis using il-17 antagonists |
AU2003263751A1 (en) * | 2002-08-05 | 2004-02-23 | Eli Lilly And Company | Novel proteins and their uses |
CA2497661A1 (en) * | 2002-09-11 | 2004-03-25 | Genentech, Inc. | Compositions and methods for the diagnosis of immune related diseases using pro71061 |
CA2638864A1 (en) * | 2006-02-10 | 2007-10-18 | Zymogenetics, Inc. | Truncated il-17ra soluble receptor and methods of using in inflammation |
US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
WO2008067057A2 (en) * | 2006-10-13 | 2008-06-05 | The Regents Of The University Of California | Cancer treatment |
WO2009069355A1 (ja) * | 2007-11-28 | 2009-06-04 | Riken | Il-17rb陽性nkt細胞を用いたアレルギー性気道炎症及び/又は気道過敏症の治療薬のスクリーニング方法 |
KR20170023209A (ko) | 2008-05-05 | 2017-03-02 | 노비뮨 에스 에이 | 항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법 |
GB0905972D0 (en) * | 2009-04-06 | 2009-05-20 | Medical Res Council | Antibodies against IL-17BR |
EP2427203B1 (en) | 2009-05-05 | 2018-10-17 | Novimmune S.A. | Anti-il-17f antibodies and use thereof |
PT3295957T (pt) | 2010-01-15 | 2019-11-12 | Kirin Amgen Inc | Formulação de anticorpo anti il-17ra e regimes terapêuticos para o tratamento de psoríase |
PE20130192A1 (es) * | 2010-03-30 | 2013-02-27 | Centocor Ortho Biotech Inc | Anticuerpos il-25 humanizados |
WO2013116682A1 (en) | 2012-02-02 | 2013-08-08 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating il-17 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL83878A (en) | 1987-09-13 | 1995-07-31 | Yeda Res & Dev | Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it |
US5106627A (en) | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
US5319071A (en) | 1987-11-25 | 1994-06-07 | Immunex Corporation | Soluble interleukin-1 receptors |
WO1989004838A1 (en) | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
IL95031A (en) | 1989-07-18 | 2007-03-08 | Amgen Inc | A method of producing a recombinant human necrotic factor absorber |
US5350683A (en) | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
CA2067031C (en) | 1991-04-26 | 2003-02-18 | Shigekazu Nagata | Dna coding for human cell surface antigen |
US5489743A (en) | 1993-01-19 | 1996-02-06 | Amgen Inc. | Transgenic animal models for thrombocytopenia |
US6664107B1 (en) | 1993-05-26 | 2003-12-16 | Ontario Cancer Institute, University Health Network | CD45 disrupted nucleic acid |
AU6760794A (en) | 1993-05-26 | 1994-12-20 | Ontario Cancer Institute, The | Transgenic mammals lacking expression of particular cd45 isoforms |
WO1995001997A1 (en) | 1993-07-09 | 1995-01-19 | Smithkline Beecham Corporation | RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN |
AU705281B2 (en) | 1994-12-23 | 1999-05-20 | Uab Research Foundation | Secreted human fas antigen |
KR19990022651A (ko) | 1995-06-07 | 1999-03-25 | 데이비드 엘. 버스테인 | 생물학적 사건에 대한 라파마이신 기재 조절방법 |
CA2244363C (en) | 1996-02-28 | 2006-11-14 | Ariad Gene Therapeutics, Inc. | Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
US6635443B1 (en) * | 1997-09-17 | 2003-10-21 | Human Genome Sciences, Inc. | Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein |
US6482923B1 (en) * | 1997-09-17 | 2002-11-19 | Human Genome Sciences, Inc. | Interleukin 17-like receptor protein |
AU2315099A (en) * | 1998-01-09 | 1999-07-26 | Immunex Corporation | Il-17rh dna and polypeptides |
AU3207000A (en) * | 1999-01-11 | 2000-08-01 | Schering Corporation | Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses |
AU4201000A (en) * | 1999-04-05 | 2000-10-23 | Incyte Pharmaceuticals, Inc. | Molecules of the immune system |
US7094886B2 (en) * | 2000-02-04 | 2006-08-22 | Board Of Trustees Of The University Of Arkansas | Evi27 gene sequences and protein encoded thereby |
JP2003523745A (ja) * | 2000-02-08 | 2003-08-12 | アムジェン インコーポレイテッド | Il−17様分子およびその使用 |
US9100155B2 (en) | 2010-05-03 | 2015-08-04 | Qualcomm Incorporated | Method and apparatus for control and data multiplexing in wireless communication |
JP6160461B2 (ja) | 2013-11-29 | 2017-07-12 | 富士通株式会社 | 尤度重み付け回路 |
-
2001
- 2001-03-15 AR ARP010101203A patent/AR030554A1/es unknown
- 2001-03-15 TW TW090106157A patent/TWI322154B/zh not_active IP Right Cessation
- 2001-03-16 AU AU5902901A patent/AU5902901A/xx active Pending
- 2001-03-16 WO PCT/US2001/008688 patent/WO2001068705A2/en active IP Right Grant
- 2001-03-16 MX MXPA02009024A patent/MXPA02009024A/es active IP Right Grant
- 2001-03-16 CA CA002401273A patent/CA2401273A1/en not_active Abandoned
- 2001-03-16 EP EP01932510A patent/EP1265924A2/en not_active Withdrawn
- 2001-03-16 JP JP2001567795A patent/JP2003527117A/ja active Pending
- 2001-03-16 AU AU2001259029A patent/AU2001259029B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU5902901A (en) | 2001-09-24 |
AU2001259029B2 (en) | 2006-01-05 |
EP1265924A2 (en) | 2002-12-18 |
MXPA02009024A (es) | 2003-02-12 |
WO2001068705A2 (en) | 2001-09-20 |
CA2401273A1 (en) | 2001-09-20 |
TWI322154B (en) | 2010-03-21 |
JP2003527117A (ja) | 2003-09-16 |
WO2001068705A3 (en) | 2002-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR030236A1 (es) | Moléculas similares a il-17 y usos de las mismas | |
AR030554A1 (es) | Moleculas similares a receptores il-17 y usos de las mismas | |
DE60237431D1 (de) | Rezeptor-selektive cannabimimetische aminoalkylindole | |
UY28348A1 (es) | Compuestos novedosos | |
ECSP088508A (es) | Antagonistas de neuropilina | |
EA200501798A1 (ru) | Новые пептиды, которые связываются с рецептором к эритропоэтину | |
EA200501430A1 (ru) | Лиганды каннабиноидных рецепторов и их применение | |
NO20030374D0 (no) | Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter | |
BRPI0113286B8 (pt) | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. | |
EA200500520A1 (ru) | Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов | |
DK0817770T3 (da) | Nonpeptider som tachykininantagonister | |
HN2004000319A (es) | "{ 1,8}naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia" | |
IT1317757B1 (it) | Metodo per la preparazione di idrocarburi idrogenati. | |
NO20010446L (no) | Substituert anilidforbindelser og metoder | |
BRPI0409133A (pt) | formulações farmacêuticas contendo metilnaltrexona | |
PA8548901A1 (es) | Ligandos del receptor 5-ht y sus usos | |
DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
ES2139959T3 (es) | Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2. | |
DE60106954D1 (de) | Resorcin-derivate | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
WO2001068859A3 (en) | Il-17 receptor like molecules and uses thereof | |
BR9809071A (pt) | Agentes farmacológicos | |
AR028579A1 (es) | Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica | |
BRPI0409359A (pt) | análogos quiméricos de somatostatina-dopamina | |
ECSP003707A (es) | Diazepanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |